Cited by 1,030Genetic Neurodegenerative DiseasesMitochondrial Function and PathologyHereditary Neurological Disorders

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Panov, Alexander V., Gutekunst, Claire-Anne, Leavitt, Blair R., Hayden, Michael R., Burke, James R., Strittmatter, Warren J., Greenamyre, J. Timothy·2002·Nature Neuroscience

DOI 10.1038/nn884

Open this paper in CoChat — free account

Abstract

Huntington's disease (HD) is caused by an expansion of exonic CAG triplet repeats in the gene encoding huntingtin protein (Htt), but the mechanisms by which this mutant protein causes neurodegeneration remain unknown. Here we show that lymphoblast mitochondria from patients with HD have a lower membrane potential and depolarize at lower calcium loads than do mitochondria from controls. We found a similar defect in brain mitochondria from transgenic mice expressing full-length mutant huntingtin, and this defect preceded the onset of pathological or behavioral abnormalities by months. By electron microscopy, we identified N-terminal mutant huntingtin on neuronal mitochondrial membranes, and by incubating normal mitochondria with a fusion protein containing an abnormally long polyglutamine repeat, we reproduced the mitochondrial calcium defect seen in human patients and transgenic animals. Thus, mitochondrial calcium abnormalities occur early in HD pathogenesis and may be a direct effect of mutant huntingtin on the organelle.

Integrity signals

Registry

Crossref · 10.1038/nn884

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770
Self-citation
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,188
Mitochondrial Transport of Cations: Channels, Exchangers, and Permeability Transition
Bernardi, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1127 · Cited by 1,546
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434
Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo
Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80514-0 · Cited by 1,291 · cited 1×
“Consistent with the toxic 'gain-of-function' hypothesis, mutant Htt self-associates and forms aggregates in a polyglutamine length–dependent manne”
Background
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B. L., Kazantsev, A., Schmidt, E., Zhu, Y.-Z., Greenwald, M., et al. (2001) · Nature · doi:10.1038/35099568 · Cited by 1,228
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease
Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., et al. (2001) · Science · doi:10.1126/science.1059581 · Cited by 1,123
Self-citation

Flagged first, then by citations

Show all 35 references

Sorted by citations

Items 601–700 of 1,000

Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi’s Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics
Szalárdy, L., Zádori, D., Klivènyi, P., Toldi, J., & Vécsei, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/498401 · Cited by 30
Altered Ca2+ signaling in skeletal muscle fibers of the R6/2 mouse, a model of Huntington’s disease
Braubach, P., Orynbayev, M., Andronache, Z., Hering, T., Landwehrmeyer, G. B., Lindenberg, K. S., & Melzer, W. (2014) · The Journal of General Physiology · doi:10.1085/jgp.201411255 · Cited by 28
Modulation of Endoplasmic Reticulum Stress: An Opportunity to Prevent Neurodegeneration?
Plácido, A. I., Pereira, C., Duarte, A. I., Candeias, E., Correia, S. C., Carvalho, C., Cardoso, S., Oliveira, C. R., & Moreira, P. I. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150429112353 · Cited by 28
DNA Repair Signaling of Huntingtin: The Next Link Between Late-Onset Neurodegenerative Disease and Oxidative DNA Damage
Maiuri, T., Bowie, L. E., & Truant, R. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4476 · Cited by 28
Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease
Lee, S., Park, J., Kim, D., Kim, S., Im, W., Kang, L., Jung, S. H., Kim, M.-W., Chu, K., & Kim, M. (2008) · Brain Research · doi:10.1016/j.brainres.2007.11.058 · Cited by 28
DRPLA transgenic mouse substrains carrying single copy of full-length mutant human DRPLA gene with variable sizes of expanded CAG repeats exhibit CAG repeat length- and age-dependent changes in behavioral abnormalities and gene expression profiles
Suzuki, K., Zhou, J., Sato, T., Takao, K., Miyagawa, T., Oyake, M., Yamada, M., Takahashi, H., Takahashi, Y., Goto, J., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.01.014 · Cited by 28
Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases
Rodolfo, C., Ciccosanti, F., Giacomo, G. D., Piacentini, M., & Fimia, G. M. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.43 · Cited by 29
Novel proteomic changes in brain mitochondria provide insights into mitochondrial dysfunction in mouse models of Huntington's disease
Agrawal, S., & Fox, J. H. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.03.004 · Cited by 28
Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models
Mallik, M., & Lakhotia, S. C. (2010) · Journal of Genetics · doi:10.1007/s12041-010-0072-4 · Cited by 27
Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
Magalhães, J. D., Fão, L., Vilaça, R., Cardoso, S. M., & Rego, A. C. (2021) · Biomedicines · doi:10.3390/biomedicines9111625 · Cited by 29
Sphingolipids and impaired hypoxic stress responses in Huntington disease
Burtscher, J., Pepe, G., Maharjan, N., Riguet, N., Pardo, A. D., Maglione, V., & Millet, G. P. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101224 · Cited by 27
Neuroprotection against neurodegenerative diseases
Chiba, T., Nishimoto, I., Aiso, S., & Matsuoka, M. (2007) · Molecular Neurobiology · doi:10.1007/bf02700624 · Cited by 27
Convergent molecular defects underpin diverse neurodegenerative diseases
Tofaris, G. K., & Buckley, N. J. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316988 · Cited by 30
Proteomic changes in the brains of Huntington's disease mouse models reflect pathology and implicate mitochondrial changes
Deschepper, M., Hoogendoorn, B., Brooks, S. P., Dunnett, S. B., & Jones, L. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.01.012 · Cited by 27
Synaptic mitochondria: A crucial factor in the aged hippocampus
Cicali, K. A., & Tapia‐Rojas, C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102524 · Cited by 27
Mitochondrial drug targets in neurodegenerative diseases
Lee, J. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.11.032 · Cited by 26
The updated development of blood-based biomarkers for Huntington’s disease
Zhang, S., Cheng, Y., & Shang, H. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11572-x · Cited by 28
Beyond CAG Repeats: The Multifaceted Role of Genetics in Huntington Disease
Pengo, M., & Squitieri, F. (2024) · Genes · doi:10.3390/genes15060807 · Cited by 27
Development and Validation of a Screening Assay for the Evaluation of Putative Neuroprotective Agents in the Treatment of Parkinson’s Disease
Yong-Kee, C. J., Salomonczyk, D., & Nash, J. E. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9174-2 · Cited by 26
Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington’s disease
Ribeiro, F. M., Hamilton, A., Doria, J. G., Guimaraes, I. M., Cregan, S. P., & Ferguson, S. S. G. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.948419 · Cited by 26
Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid
Blum, D. L., Hemming, F. J., Galas, M., Torch, S., Cuvelier, L., Schiffmann, S. N., & Sadoul, R. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.07.046 · Cited by 26
The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review
Walsh, R., Storey, E., Stefani, D., Kelly, L. C., & Turnbull, V. J. (2005) · Neurotoxicity Research · doi:10.1007/bf03033775 · Cited by 26
Altered distribution of striatal activity-dependent synaptic plasticity in the 3-nitropropionic acid model of Huntington's disease
Dalbem, A., Silveira, C. V., Pedroso, M. F., Breda, R. V., Baes, C. V. W., Bartmann, A. P., & da Costa, J. C. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.030 · Cited by 26
Raft-like microdomains play a key role in mitochondrial impairment in lymphoid cells from patients with Huntington's disease
Ciarlo, L., Manganelli, V., Matarrese, P., Garofalo, T., Tinari, A., Gambardella, L., Marconi, M., Grasso, M., Misasi, R., Sorice, M., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m026062 · Cited by 27
Protein interacting with C kinase (PICK1) is a suppressor of spinocerebellar ataxia 3-associated neurodegeneration in Drosophila
McGurk, L., & Bonini, N. M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr439 · Cited by 26
The Interface between Cytoskeletal Aberrations and Mitochondrial Dysfunction in Alzheimer's Disease and Related Disorders
Kang, D. E., Roh, S. E., Woo, J. A., Liu, T., Bu, J. H., Jung, A., & Lim, Y. (2011) · Experimental Neurobiology · doi:10.5607/en.2011.20.2.67 · Cited by 26
Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility
Cherubini, M., & Ginés, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.042 · Cited by 28
Re-engineering the mitochondrial genomes in mammalian cells
Yoon, Y. G., Koob, M. D., & Yoo, Y. H. (2010) · Anatomy & Cell Biology · doi:10.5115/acb.2010.43.2.97 · Cited by 26
Targeting aggregation in the development of therapeutics for the treatment of Huntington?s disease and other polyglutamine repeat diseases
Steffan, J. S., & Thompson, L. M. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.2.201 · Cited by 26
C. elegans as an Animal Model to Study the Intersection of DNA Repair, Aging and Neurodegeneration
Naranjo-Galindo, F. J., Ai, R., Fang, E. F., Nilsen, H. L., & SenGupta, T. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.916118 · Cited by 29
Seeking Brain Biomarkers for Preventive Therapy in Huntington Disease
Esmaeilzadeh, M., Ciarmiello, A., & Squitieri, F. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00157.x · Cited by 25
The therapeutic potential of G-protein coupled receptors in Huntington's disease
Dowie, M. J., Scotter, E. L., Molinari, E., & Glass, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.008 · Cited by 26
Differential effects of the Huntington's disease CAG mutation in striatum and cerebellum are quantitative not qualitative
Fossale, E., Seong, I. S., Coser, K. R., Shioda, T., Kohane, I. S., Wheeler, V. C., Gusella, J. F., MacDonald, M. E., & Lee, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr355 · Cited by 25
Mitochondrial Respiratory Function in Peripheral Blood Cells from Huntington's Disease Patients
Ehinger, J. K., Morota, S., Hansson, M. J., Paul, G., & Elmér, E. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12308 · Cited by 25
Assessing Mitochondrial Function in In Vitro and Ex Vivo Models of Huntington’s Disease
Ferreira, I. L., Carmo, C., Naia, L., Mota, S. I., & Rego, A. C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7825-0_19 · Cited by 25
Deterioration of mitochondrial bioenergetics and ultrastructure impairment in skeletal muscle of a transgenic minipig model in the early stages of Huntington's disease
Rodinová, M., Křížová, J., Štufková, H., Bohuslavová, B., Askeland, G., Dosoudilova, Z., Juhás, Š., Juhásová, J., Ellederová, Z., Zeman, J., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.038737 · Cited by 25
Forebrain Striatal-Specific Expression of Mutant Huntingtin Proteinin VivoInduces Cell-Autonomous Age-Dependent Alterations in Sensitivity to Excitotoxicity and Mitochondrial Function
Kim, S. H., Thomas, C. A., André, V. M., Cummings, D. M., Cepeda, C., Michael, S. L., & Ehrlich, M. E. (2011) · ASN NEURO · doi:10.1042/an20110009 · Cited by 25
Huntington’s disease: how does huntingtin, an anti-apoptotic protein, become toxic?
Rangone, H., Humbert, S., & Saudou, F. (2004) · Pathologie Biologie · doi:10.1016/j.patbio.2003.06.004 · Cited by 25
Nucleocytoplasmic transport signals affect the age at onset of abnormalities in knock-in mice expressing polyglutamine within an ectopic protein context
Jackson, W. S. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg163 · Cited by 25
RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington’s disease models
Lin, Y., Li, C., Chen, Y., Gao, J., Li, J., Huang, C., Liu, Z., Wang, W., Zheng, X., Song, X., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00794-w · Cited by 26
hMTH1 expression protects mitochondria from Huntington's disease-like impairment
Ventura, I., Russo, M. T., Nuccio, C. D., Luca, G. D., Degan, P., Bernardo, A., Visentin, S., Minghetti, L., & Bignami, M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.09.002 · Cited by 24
Quercetin improves the activity of the ubiquitin‐proteasomal system in 150Q mutated huntingtin‐expressing cells but exerts detrimental effects on neuronal survivability
Chakraborty, J., Rajamma, U., Jana, N. R., & Mohanakumar, K. P. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23618 · Cited by 24
The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease
Wang, Q., Liang, G., Yang, H., Wang, S., Eckenhoff, M. F., & Wei, H. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.10.032 · Cited by 24
Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease
Napolitano, M., Centonze, D., Gubellini, P., Rossi, S., Spiezia, S., Bernardi, G., Gulino, A., & Calabresi, P. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.11.021 · Cited by 24
Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity
Xifró, X., Anglada‐Huguet, M., Rué, L., Saavedra, A., Pérez‐Navarro, E., & Alberch, J. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-74 · Cited by 24
Oxidative metabolism and Ca 2+ handling in striatal mitochondria from YAC128 mice, a model of Huntington's disease
Hamilton, J., Brustovetsky, T., & Brustovetsky, N. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.01.001 · Cited by 24
Mitochondrial contributions to neuronal development and function
Princz, A., Kounakis, K., & Tavernarakis, N. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0333 · Cited by 25
Mitochondrial membranes modify mutant huntingtin aggregation
Adegbuyiro, A., Sedighi, F., Jain, P., Pinti, M. V., Siriwardhana, C., Hollander, J. M., & Legleiter, J. A. (2021) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2021.183663 · Cited by 24
Alterations of Calcium Channels in a Mouse Model of Huntington’s Disease and Neuroprotection by Blockage of Ca V 1 Channels
Santos‐Miranda, A., Cardozo, P. L., da Silva, F. R., de Souza, J. M., Olmo, I. G., Cruz, J. S., Gomez, M. V., Ribeiro, F. M., & Vieira, L. B. (2019) · ASN NEURO · doi:10.1177/1759091419856811 · Cited by 23
Acquired axonal degeneration and regeneration
Benarroch, E. E. (2015) · Neurology · doi:10.1212/wnl.0000000000001601 · Cited by 24
Neurotoxicity Pathways in Drosophila Models of the Polyglutamine Disorders
Krench, M., & Littleton, J. T. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.07.006 · Cited by 23
Muscle atrophy is associated with cervical spinal motoneuron loss in BACHD mouse model for Huntington's disease
Valadão, P. A. C., de Aragão, B. C., Andrade, J. N., Magalhães-Gomes, M. P. S., Foureaux, G., Joviano‐Santos, J. V., Nogueira, J. C., Ribeiro, F. M., Tapia, J. C., & Guatimosim, C. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13510 · Cited by 23
Anti-human placental antigen complex X-P2 (hPAX-P2) anti-serum recognizes C-terminus of huntingtin-associated protein 1A common to 1B as a determinant marker for the stigmoid body
Fujinaga, R., Yanai, A., Nakatsuka, H., Yoshida, K., Takeshita, Y., Uozumi, K., Zhao, C., Hirata, K., Kokubu, K., Nagano, M., et al. (2007) · Histochemistry and Cell Biology · doi:10.1007/s00418-007-0315-5 · Cited by 23
Selective striatal mtDNA depletion in end-stage Huntington's disease R6/2 mice
Hering, T., Birth, N., Taanman, J., & Orth, M. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.02.004 · Cited by 23
Huntington's disease
Hersch, S. M. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000084229.82329.03 · Cited by 23
Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases
Yusoff, A. A. M., & Khair, S. Z. N. M. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0080 · Cited by 23
Mitochondria from huntington´s disease striatal astrocytes are hypermetabolic and compromise neuronal branching
López-Molina, L., Pereda-Velarde, A., Franco, N. D., Aerts, I., Sebastiá, E. M., Valls‐Roca, L., Guitart‐Mampel, M., Garrabou, G., & Ginés, S. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02341-6 · Cited by 23
Amitriptyline Improves Motor Function via Enhanced Neurotrophin Signaling and Mitochondrial Functions in the Murine N171-82Q Huntington Disease Model
Cong, W., Chadwick, W., Wang, R., Daimon, C. M., Cai, H., Amma, J., Wood, W. H., Becker, K. G., Martin, B., & Maudsley, S. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.588608 · Cited by 22
Effects of estrogens and androgens on mitochondria under normal and pathological conditions
Mohajeri, M., Martín-Jiménez, C., Barreto, G. E., & Sahebkar, A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.03.001 · Cited by 23
Protective Effects of Interrupting the Binding of Calmodulin to Mutant Huntingtin
Dudek, N. L., Dai, Y., & Muma, N. A. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816a9e60 · Cited by 22
Pathways of neurodegeneration and experimental models of basal ganglia disorders: Downstream effects of mitochondrial inhibition
Filippo, M. D., Picconi, B., Costa, C., Bagetta, V., Tantucci, M., Parnetti, L., & Calabresi, P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.024 · Cited by 25
Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington’s disease R6/2 model
Im, W., Ban, J., Chung, J. Y., Lee, S., Chu, K., & Kim, M. (2015) · Scientific Reports · doi:10.1038/srep16887 · Cited by 21
Calretinin interacts with huntingtin and reduces mutant huntingtin‐caused cytotoxicity
Dong, G., Gross, K., Qiao, F., Ferguson, J., Callegari, E. A., Rezvani, K. S., Zhang, D., Gloeckner, C. J., Ueffing, M., & Wang, H. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07919.x · Cited by 21
Brain region specificity of 3-nitropropionic acid-induced vulnerability of neurons involves cytochrome c oxidase
Singh, S., Misiak, M., Beyer, C., & Arnold, S. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.06.008 · Cited by 21
Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis
Nóbrega, C., Simões, A. T., Duarte‐Neves, J., Duarte, S., Vasconcelos‐Ferreira, A., Cunha‐Santos, J., Pereira, D., Santana, M. M., Cavadas, C., & de Almeida, L. P. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-71779-1_18 · Cited by 22
Reactive Oxygen Species in Neurodegenerative Diseases: Implications in Pathogenesis and Treatment Strategies
Oladele, J. O., Oladiji, A. T., Oladele, O. T., & Oyeleke, O. M. (2021) · Biochemistry · doi:10.5772/intechopen.99976 · Cited by 21
Molecular biology of Huntington's disease
McFarland, K. N., & Cha, J.-H. J. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52014-2.00003-3 · Cited by 21
A mitochondrial basis for Huntington’s disease: therapeutic prospects
Chakraborty, J., Rajamma, U., & Mohanakumar, K. P. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1951-9 · Cited by 21
Ribosome Profiling and Mass Spectrometry Reveal Widespread Mitochondrial Translation Defects in a Striatal Cell Model of Huntington Disease
Dagar, S., Sharma, M., Tsaprailis, G., Scharager-Tapia, C., Crynen, G. C., Joshi, P. S., Shahani, N., & Subramaniam, S. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100746 · Cited by 20
Gene Therapy in Mouse Models of Huntington Disease
Southwell, A. L., & Patterson, P. H. (2011) · The Neuroscientist · doi:10.1177/1073858410386236 · Cited by 20
Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset
Gardiner, S. L., Milanese, C., Boogaard, M. W., Buijsen, R. A. M., Hogenboom, M., Roos, R. A. C., Mastroberardino, P. G., van Roon‐Mom, W., & Aziz, N. A. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000275 · Cited by 20
MERCs. The Novel Assistant to Neurotransmission?
Shirokova, O. M., Pchelin, P. V., & Mukhina, I. V. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.589319 · Cited by 20
Deciphering the key mechanisms leading to alteration of lipid metabolism in Drosophila model of Huntington's disease
Singh, A., & Agrawal, N. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166127 · Cited by 20
NMDA Receptors and Huntington’s Disease
Fernandes, H. B., & Raymond, L. A. (2008) · Frontiers in neuroscience · doi:10.1201/9781420044157.ch2 · Cited by 21
Telomere length analysis on leukocytes derived from patients with Huntington Disease
PerezGrovas-Saltijeral, A., Ochoa-Morales, A., Miranda-Duarte, A., Martínez-Ruano, L., Jara-Prado, A., Camacho-Molina, A., & Hidalgo-Bravo, A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111189 · Cited by 19
Mitochondrial DNA: a molecular switch driving sterile neuroinflammation
Jauhari, A., Singh, T., Carlisle, D. L., & Friedlander, R. M. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00540-w · Cited by 20
HSF1 and Its Role in Huntington’s Disease Pathology
Kim, H., & Gómez‐Pastor, R. (2022) · Advances in experimental medicine and biology · doi:10.1007/5584_2022_742 · Cited by 21
Experimental Models of HD and Reflection on Therapeutic Strategies
Kim, J., Bordiuk, O. L., & Ferrante, R. J. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00016-x · Cited by 20
Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin
Ruan, Q., Quintanilla, R. A., & Johnson, G. V. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04491.x · Cited by 19
Mitochondrial and metabolic-based protective strategies in Huntington’s disease: the case of creatine and coenzyme Q
Naia, L., Ribeiro, M. J., & Rego, A. C. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.060 · Cited by 19
Therapeutic potential of ginsenoside Rg3 and Rf for Huntington’s disease
Lee, M., Ban, J., Won, B. H., Im, W., & Kim, M. (2021) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-021-00595-1 · Cited by 20
Brain region-specific vulnerability of astrocytes in response to 3-nitropropionic acid is mediated by cytochrome c oxidase isoform expression
Misiak, M., Singh, S., Drewlo, S., Beyer, C., & Arnold, S. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-0995-3 · Cited by 19
Calcium Handling by Endoplasmic Reticulum and Mitochondria in a Cell Model of Huntington’s Disease
Mario, A. D., Scarlatti, C., Costiniti, V., Primerano, S., Lopreiato, R., Calí, T., Brini, M., Giacomello, M., & Carafoli, E. (2016) · PLoS Currents · doi:10.1371/currents.hd.37fcb1c9a27503dc845594ee4a7316c3 · Cited by 19
Polyglutamine Disorders Including Huntington's Disease
Todi, S. V., Williams, A. J., & Paulson, H. L. (2007) · Elsevier eBooks · doi:10.1016/b978-012369509-3.50019-6 · Cited by 19
Structural Properties of Polyglutamine Aggregates Investigated via Molecular Dynamics Simulations
Rossetti, G., Magistrato, A., Pastore, A., Persichetti, F., & Carloni, P. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp806548p · Cited by 18
Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntington’s disease
Hyeon, S. J., Park, J., Yoo, J., Kim, S., Hwang, Y. J., Kim, S.-C., Liu, T., Shim, H. S., Kim, Y., Cho, Y., et al. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102110 · Cited by 18
Dopamine D1 receptor–mediated aggregation of N-terminal fragments of mutant huntingtin and cell death in a neuroblastoma cell line
Robinson, P., Lebel, M., & Cyr, M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.052 · Cited by 18
Mitochondrial calcium handling and neurodegeneration: when a good signal goes wrong
Filadi, R., & Pizzo, P. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2020.08.009 · Cited by 18
Fish Models for Exploring Mitochondrial Dysfunction Affecting Neurodegenerative Disorders
Otsuka, T., & Matsui, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087079 · Cited by 17
GLUT-1 changes in paediatric Huntington disease brain cortex and fibroblasts: an observational case-control study
Tramutola, A., Bakels, H. S., Perrone, F., Nottia, M. D., Mazza, T., Abruzzese, M. P., Zoccola, M., Pagnotta, S. E., Carrozzo, R., de Bot, S. T., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104849 · Cited by 17
Attenuation of polyglutamine-induced toxicity by enhancement of mitochondrial OXPHOS in yeast and fly models of aging
Ruetenik, A., Ocampo, A., Ruan, K., Zhu, Y., Li, C. V., Zhai, R. G., & Barrientos, A. (2016) · Microbial Cell · doi:10.15698/mic2016.08.518 · Cited by 18
Exploiting Post-mitotic Yeast Cultures to Model Neurodegeneration
Ruetenik, A., & Barrientos, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00400 · Cited by 18
Altered Ca2+ Homeostasis in Immune Cells during Aging: Role of Ion Channels
Zöphel, D., Hof, C., & Lis, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010110 · Cited by 17
Lymphoblastoid Cell Lines as Models to Study Mitochondrial Function in Neurological Disorders
Annesley, S. J., & Fisher, P. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094536 · Cited by 17
IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats
Escartin, C., Boyer, F., Bemelmans, A., Hantraye, P., & Brouillet, E. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.08.031 · Cited by 17
Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington?s disease
Zucker, B., Ludin, D., Gerds, T. A., L�cking, C. H., Landwehrmeyer, G. B., & Feuerstein, T. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0959-9 · Cited by 17
Longitudinal spatial mapping of lipid metabolites reveals pre-symptomatic changes in the hippocampi of Huntington's disease transgenic mice
Farzana, F., McConville, M. J., Renoir, T., Li, S., Nie, S., Tran, H., Hannan, A. J., Hatters, D. M., & Boughton, B. A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105933 · Cited by 18
Cholesterol impacts the formation of huntingtin/lipid complexes and subsequent aggregation
Stonebraker, A. R., Beasley, M. A., Massinople, S. E., Wunder, M. M., Li, P., Valentine, S. J., & Legleiter, J. A. (2023) · Protein Science · doi:10.1002/pro.4642 · Cited by 16
Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3) has a key role in the mitochondrial dysfunction induced by mutant huntingtin
Sassone, F., Margulets, V., Maraschi, A., Rodighiero, S., Passafaro, M., Silani, V., Ciammola, A., Kirshenbaum, L. A., & Sassone, J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv362 · Cited by 16
Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease
Choi, K., Hwang, I.-S., Park, H.-S., Oh, S., Kang, S., & Hong, S. (2014) · Biotechnology Journal · doi:10.1002/biot.201300560 · Cited by 16

Authors: Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T.
Affiliations: Emory University (US)
University of British Columbia (CA)
Duke Medical Center (US)
Corresponding author: Greenamyre, J. Timothy
ORCID: Panov, Alexander V.
Gutekunst, Claire-Anne
Leavitt, Blair R.
Hayden, Michael R.
Burke, James R.
Greenamyre, J. Timothy
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2002-07-01
Volume: 5
Issue: 8
Pages: 731-736
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/nn884
OpenAlex: W1972771185
Cited by: 1,030
References: 35
Citations by year: 2026: 16 · 2025: 23 · 2024: 26 · 2023: 27 · 2022: 30 · 2021: 49 · 2020: 29 · 2019: 35 · 2018: 39 · 2017: 23 · 2016: 45 · 2015: 35 · 2014: 48 · 2013: 33 · 2012: 68
FWCI: 19.24
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ag014648-05)
National Institute on Aging (AG14648)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords: Huntington's disease, mitochondrial calcium handling, polyglutamine expansion, mutant huntingtin, mitochondrial membrane potential, mitochondrial depolarization, neurodegeneration, transgenic mice, early pathogenesis
MeSH terms: Huntingtin Protein, Animals, Brain, Brain Chemistry, Calcium, Cell Line, Disease Models, Animal, Humans, Huntington Disease, Intracellular Membranes, Lymphocytes, Membrane Potentials, Mice, Transgenic, Microscopy, Electron, Mitochondria, Nerve Tissue Proteins, Nuclear Proteins, Recombinant Fusion Proteins, Trinucleotide Repeat Expansion, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks